olanzapine 15 MG Disintegrating Oral Tablet

Known as: OLANZAPINE 15MG,TAB RAPID DISINTEGRATING [VA Product], OLANZAPINE 15 mg ORAL TABLET, ORALLY DISINTEGRATING [Olanzapine], Olanzapine 15 mg ORAL TABLET, ORALLY DISINTEGRATING 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2014
01220042014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Little is known about the long-term changes in the functioning of schizophrenia patients receiving maintenance therapy… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2014
2014
BACKGROUND The incidence of extrapyramidal symptoms (EPS) has been shown to be generally low among patients with schizophrenia… (More)
Is this relevant?
2013
Review
2013
Review
2013
Background: Hospitalization is a costly and distressing event associated with relapse during schizophrenia treatment. No… (More)
Is this relevant?
Review
2012
Review
2012
OBJECTIVE To assess the effects of olanzapine long-acting injection (olanzapine-LAI) on levels of functioning in acutely ill… (More)
Is this relevant?
2004
2004
The purpose of this research project was to investigate potential matrix effects of anticoagulant and lipemia on the response of… (More)
Is this relevant?